MammaTyper, part of Biontech Diagnostics, provides molecular diagnostics technology. The company is providing an in-vitro diagnostic test for the quantitative detection of the mRNA expression of ERBB2, ESR1, PGR, and MKI67. The test is meant for detecting breast cancer tissue.